Patents matching “treatment”

US 11583540

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

Windtree Therapeutics, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

US 11583526

Treatment of prostate cancer

Takeda Pharmaceutical Company Limited · Granted Feb 21, 2023 · Expires Feb 16, 2043

US 11583530

Compounds for the prevention and treatment of medical disorders and uses thereof

Galectin Sciences, LLC · Granted Feb 21, 2023 · Expires Feb 16, 2043

US 11576983

Treatments for retinal disease

4D MOLECULAR THERAPEUTICS INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

US 11576924

Compounds for the prevention and treatment of diseases and the use thereof

Galectin Sciences, LLC · Granted Feb 14, 2023 · Expires Feb 9, 2043

US 11571446

Gut microbiota and treatment of cancer

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 7, 2023 · Expires Feb 2, 2043

US 11572408

Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent

VACCINEX, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

US 11571440

Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion

Jazz Pharmaceuticals Ireland Limited · Granted Feb 7, 2023 · Expires Feb 2, 2043

US 11572588

Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases

The Regents of the University of Colorado, a Body Corporate · Granted Feb 7, 2023 · Expires Feb 2, 2043

US 11572541

Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

Providence Health & Services—Oregon · Granted Feb 7, 2023 · Expires Feb 2, 2043

US 11564896

Methods of treatment

First Wave Bio, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

US 11566236

Materials and methods for treatment of hemoglobinopathies

Vertex Pharmaceuticals Incorporated · Granted Jan 31, 2023 · Expires Jan 26, 2043

US 11564997

Materials and methods for treatment of friedreich ataxia and other related disorders

CRISPR THERAPEUTICS AG · Granted Jan 31, 2023 · Expires Jan 26, 2043

US 11560366

Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

The Board of Regents of the University of Texas System · Granted Jan 24, 2023 · Expires Jan 19, 2043

US 11560370

5-membered heteroaryl carboxamide compounds for treatment of HBV

ASSEMBLY BIOSCIENCES, INC. · Granted Jan 24, 2023 · Expires Jan 19, 2043

US 11559588

Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders

CRISPR THERAPEUTICS AG · Granted Jan 24, 2023 · Expires Jan 19, 2043

US 11560356

Compounds and compositions for the treatment of cancer

The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

US 11554102

Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

Jazz Pharmaceuticals Ireland Limited · Granted Jan 17, 2023 · Expires Jan 12, 2043

US 11549147

Treatment of atopic dermatitis with tradipitant

VANDA PHARMACEUTICALS INC. · Granted Jan 10, 2023 · Expires Jan 5, 2043

US 11548951

Compositions and methods for treatment of thyroid eye disease

Viridian Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

US 11542302

Modulators of melanocortin receptors for the treatment of depression and anxiety

Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 3, 2023 · Expires Dec 29, 2042

US 11541075

Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

ANIKA THERAPEUTICS, INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

US 11535851

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

Benitec IP Holdings Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

US 11534465

Fecal matter for treatment of autoimmune diseases

ACADEMISCH MEDISCH CENTRUM · Granted Dec 27, 2022 · Expires Dec 22, 2042